Eaton Vance Management Has $139.26 Million Position in CVS Health Corp (CVS)

Share on StockTwits

Eaton Vance Management cut its holdings in CVS Health Corp (NYSE:CVS) by 0.4% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,769,069 shares of the pharmacy operator’s stock after selling 6,983 shares during the period. Eaton Vance Management’s holdings in CVS Health were worth $139,261,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CVS. BlackRock Inc. boosted its holdings in CVS Health by 5.9% in the 2nd quarter. BlackRock Inc. now owns 74,135,102 shares of the pharmacy operator’s stock worth $4,770,597,000 after buying an additional 4,121,620 shares during the period. Charles Schwab Investment Advisory Inc. bought a new position in CVS Health in the 2nd quarter worth approximately $190,701,000. Boston Partners boosted its holdings in CVS Health by 41.9% in the 2nd quarter. Boston Partners now owns 9,908,888 shares of the pharmacy operator’s stock worth $637,637,000 after buying an additional 2,924,875 shares during the period. Morgan Stanley boosted its holdings in CVS Health by 28.4% in the 2nd quarter. Morgan Stanley now owns 8,358,263 shares of the pharmacy operator’s stock worth $537,854,000 after buying an additional 1,848,678 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec boosted its holdings in CVS Health by 52.1% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 5,171,271 shares of the pharmacy operator’s stock worth $332,771,000 after buying an additional 1,771,170 shares during the period. 84.50% of the stock is owned by institutional investors.

NYSE CVS opened at $74.09 on Friday. CVS Health Corp has a 1 year low of $60.14 and a 1 year high of $83.88. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.94 and a current ratio of 2.44. The company has a market capitalization of $78.01 billion, a price-to-earnings ratio of 11.23, a PEG ratio of 1.10 and a beta of 0.98.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The business had revenue of $47.27 billion for the quarter, compared to analysts’ expectations of $47.22 billion. During the same period in the prior year, the company posted $1.50 EPS. The business’s revenue for the quarter was up 2.4% compared to the same quarter last year. As a group, research analysts forecast that CVS Health Corp will post 7.03 EPS for the current fiscal year.

Several research analysts recently commented on the stock. Argus raised their price objective on shares of CVS Health to $100.00 and gave the stock a “buy” rating in a report on Tuesday, November 13th. Loop Capital set a $80.00 target price on shares of CVS Health and gave the stock a “hold” rating in a research note on Wednesday, November 28th. Evercore ISI started coverage on shares of CVS Health in a research note on Wednesday, November 28th. They issued an “outperform” rating and a $89.00 target price on the stock. Goldman Sachs Group reiterated a “neutral” rating and issued a $87.00 target price on shares of CVS Health in a research note on Thursday, November 29th. Finally, Cantor Fitzgerald started coverage on shares of CVS Health in a research note on Sunday, December 2nd. They issued an “overweight” rating and a $77.84 target price on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $90.69.

In other news, CFO David M. Denton sold 25,159 shares of the firm’s stock in a transaction on Thursday, November 29th. The shares were sold at an average price of $80.13, for a total transaction of $2,015,990.67. Following the sale, the chief financial officer now owns 403 shares in the company, valued at approximately $32,292.39. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Eva C. Boratto sold 13,311 shares of the firm’s stock in a transaction on Monday, September 17th. The shares were sold at an average price of $77.16, for a total transaction of $1,027,076.76. Following the sale, the executive vice president now owns 55,162 shares in the company, valued at approximately $4,256,299.92. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 74,233 shares of company stock worth $5,932,565. Corporate insiders own 0.53% of the company’s stock.

TRADEMARK VIOLATION WARNING: This story was originally published by BBNS and is the property of of BBNS. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://baseballnewssource.com/2018/12/08/eaton-vance-management-has-139-26-million-position-in-cvs-health-corp-cvs/3064109.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Story: How Do I Invest in Dividend Stocks

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.